Serologic Response to Messenger RNA Coronavirus Disease 2019 Vaccines in Inflammatory Bowel Disease Patients Receiving Biologic Therapies is a research paper published in Gastroenterology (2021). On theSindex it has a DataRank of 0. It has been cited 141 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Center for Advancing Translational Sciences
Grant: CA224319
National Center for Advancing Translational Sciences
Grant: DK124165
National Institutes of Health
Grant: 75N91019D00024
National Institutes of Health
Grant: 75N91020F00003
National Institutes of Health
Grant: UL1TR001433
NCATS NIH HHS
Grant: UL1 TR004419
Crohn's & Colitis Foundation
Grant: 596936
NIDDK NIH HHS
Grant: U01 DK124165
NCI NIH HHS
Grant: U24 CA224319
National Institutes of Health
Grant: 5U24CA224319-04
High-Dimensional Immune Monitoring of NCI-Supported Immunotherapy Trials
National Institutes of Health
Grant: 5UL1TR001433-02
MSHS Translational Science Hub
Shire
Grant: unidentified
unidentified
National Institutes of Health
Grant: 5U01DK124165-02
Characterizing and predicting colitis in immune checkpoint blockade-treated cancer patients
Ferring Pharmaceuticals
Genentech
Icahn School of Medicine at Mount Sinai
Takeda Pharmaceutical Company
Shire
U.S. Department of Health and Human Services
AbbVie
Merck
Neos Therapeutics
Government of South Australia
Janssen Pharmaceuticals
Pfizer
Sanofi
Leona M. and Harry B. Helmsley Charitable Trust
National Cancer Institute
Fields of Study
MeSH Terms
Keywords